Pentokey Organy (India) Share Price
32.61+0.00 (+0.00%)
-22.54% past 1 Year
Pentokey Organy (India) Ltd was incorporated on 26th November 1986 .The Company is engaged in the business of manufacturing chemicals such as Acetic Acid Ethyl Acetate and Acetaldehyde The factory
Corporate filings & documents
Announcements
Pursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the Annual Report for the financial year ended 31st March 2026 along with the Notice of the 39th Annual General Meeting of the Company to be held on Saturday 26th September 2026 at 3.00 p.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
16 hours agoPursuant to Regulations 30 and 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed the Annual Report for the financial year ended 31st March 2026 along with the Notice of the 39th Annual General Meeting of the Company to be held on Saturday 26th September 2026 at 3.00 p.m. through Video Conferencing (VC)/ Other Audio Visual Means (OAVM).
16 hours agoBoard of Directors in the meeting held on 13th August 2026 have decided the AGM date for the Financial Year ended 31st March 2026 to be held on 26th September 2026.
3 weeks agoBoard of Directors in the meeting held on 13th August 2026 have decided the AGM date for the Financial Year ended 31st March 2026 to be held on 26th September 2026.
3 weeks agoAppointment of Independent Women Director
3 weeks agoAppointment of Independent Women Director
3 weeks agostandalone unaudited Financial Result for the quarter ended 30th June 2026
3 weeks agostandalone unaudited Financial Result for the quarter ended 30th June 2026
3 weeks agoThis is to inform you that pursuant to Regulation 30 & Regulation 33 of Securities Exchange Board of India (Listing Obligation and Disclosure requirement) Regulation 2015 Listing regulation and other applicable provisions the Board of Directors of the company at its meeting held today have approved the Un- Audited Financial Results of the Company for the quarter ended 30th June 2026.A copy of the unaudited Financial Results along with the limited review report of the statutory auditors of the company on the financial results are enclosed herewith.The meeting of the Board of Directors of the Company commenced at 12.30 PM and concluded at 01.10 PM
3 weeks agoThis is to inform you that pursuant to Regulation 30 & Regulation 33 of Securities Exchange Board of India (Listing Obligation and Disclosure requirement) Regulation 2015 Listing regulation and other applicable provisions the Board of Directors of the company at its meeting held today have approved the Un- Audited Financial Results of the Company for the quarter ended 30th June 2026.A copy of the unaudited Financial Results along with the limited review report of the statutory auditors of the company on the financial results are enclosed herewith.The meeting of the Board of Directors of the Company commenced at 12.30 PM and concluded at 01.10 PM
3 weeks agoPentokey Organy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 13th August 2026 to inter alia to consider and approve the unaudited Financial Results of the Company for the quarter ended 30th June 2026.Further the Trading Window for dealing in securities of the Company which is currently closed in pursuance of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 read with Companys Code of Conduct for Prevention of Insider Trading shall reopen 48 hours after the financial results of the Company for the quarter ended 30th June 2026 become generally available.
3 weeks agoPentokey Organy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 13th August 2026 to inter alia to consider and approve the unaudited Financial Results of the Company for the quarter ended 30th June 2026.Further the Trading Window for dealing in securities of the Company which is currently closed in pursuance of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 read with Companys Code of Conduct for Prevention of Insider Trading shall reopen 48 hours after the financial results of the Company for the quarter ended 30th June 2026 become generally available.
3 weeks agoWe are enclosing herewith certificate received from RTA Datamatics Business solutions Limited pursuant to regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026.
1 month agoWe are enclosing herewith certificate received from RTA Datamatics Business solutions Limited pursuant to regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 30th June 2026.
1 month agoThe trading window of the company for trading/dealing in securities shall remain closed from 1st July 2026 and shall re open 48 hours after the unaudited Financial results of the company for the quarter ended 30th June 2026 become generally available.
2 months agoOur Company falls under criteria as specified under regulation 15(2) of SEBI LODR as such we hereby submit non applicablity of Annual secretarial compliance report along with net worth certificate received from statutory auditor.
3 months agoAudited standalone Financial Result for quarter and Financial year ended 31st march 2026.
3 months agoAudited standalone Financial Result for quarter and Financial year ended 31st march 2026.
3 months agoThis is to inform you that pursuant to Regulation 30 & Regulation 33 of Securities Exchange Board of India (Listing Obligation and Disclosure requirement) Regulation 2015 Listing regulation and other applicable provisions the Board of Directors of the company at its meeting held today have approved the Audited Financial Results of the Company for the quarter and year ended 31st March 2026.A copy of the audited Financial Results along with the audit report of the statutory auditors of the company on the financial results are enclosed herewith.Unmodified Opinion:Further this is hereby declared that M/s Verma Mehta & Associates the Statutory Auditors of the Company have issued Auditors Report with an unmodified opinion on the Audited Financial Statements for the quarter and financial year ended March 31 2026. This declaration is made pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.
3 months agoPentokey Organy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 30th May 2026 to inter alia to consider and approve the Audited Financial Results of the Company for the quarter and year ended 31st March 2026.
3 months agoIn complianc with reg 74(5) of SEBI (DP) Reg 2018 we are enclosing herewith certificate received from Datamatics Business solutions Ltd. the Registrar and share transfer agent of the company for the quarter ended 31st March 2026.
4 months agoIn complianc with reg 74(5) of SEBI (DP) Reg 2018 we are enclosing herewith certificate received from Datamatics Business solutions Ltd. the Registrar and share transfer agent of the company for the quarter ended 31st March 2026.
4 months agoTrading window for trading/dealing in securities shall remain closed from 1st April 2026 and shall re open 48 hours after the financial statement for the quarter and year ended 31st March 2026 become generally available.
5 months agoTrading window for trading/dealing in securities shall remain closed from 1st April 2026 and shall re open 48 hours after the financial statement for the quarter and year ended 31st March 2026 become generally available.
5 months agounaudited Financial result for the quarter and nine months ended 31st December 2025.
7 months agoThis is to inform you that pursuant to Regulation 30 & Regulation 33 of Securities Exchange Board of India (Listing Obligation and Disclosure requirement) Regulation 2015 Listing regulation and other applicable provisions the Board of Directors of the company at its meeting held today have approved the Un- Audited Financial Results of the Company for the quarter and nine months ended 31st December 2025.A copy of the unaudited Financial Results along with the limited review report of the statutory auditors of the company on the financial results are enclosed herewith.The meeting of the Board of Directors of the Company commenced at 4.00 PM and concluded at 4.30 PM
7 months agoPentokey Organy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (ListingObligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) it is herebyinformed that a meeting of the Board of Directors of the Company is scheduled to be held onWednesday 21st January 2026 to inter alia to consider and approve the unaudited Financial Resultsof the Company for the quarter ended 31st December 2025.Further the Trading Window for dealing in securities of the Company which is currently closed inpursuance of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 read with Companys Code of Conduct for Prevention of Insider Trading shall reopen 48 hoursafter the financial results of the Company for the quarter ended 31st December 2025 become generallyavailableThe intimation is also being uploaded on the Companys website http://www.pentokey.com
7 months agoWe are enclosing herewith copy of cerificate issued from Datatmatics Business Solutions Ltd the registrar and share transfer agent of the company for the quarter ended 31st December 2025
7 months agoTrading window for trading /dealing in securities shall remain close from 1st January 2026 and shall repoen 48 hours after the Financial result for the quarter ended 31st December 2025 shall become generally available.
8 months agoUnaudited financial result for the quarter and half year ended 30th September 2025
10 months agoThis is to inform you that pursuant to Regulation 30 & Regulation 33 of Securities Exchange Board of India (Listing Obligation and Disclosure requirement) Regulation 2015 Listing regulation and other applicable provisions the Board of Directors of the company at its meeting held today have approved the Un- Audited Financial Results of the Company for the quarter and half year ended 30th september 2025.A copy of the unaudited Financial Results along with the limited review report of the statutory auditors of the company on the financial results are enclosed herewith.The meeting of the Board of Directors of the Company commenced at 11.00 AM and concluded at 11.45 AM
10 months agoPentokey Organy India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations) it is hereby informed that a meeting of the Board of Directors of the Company is scheduled to be held on Saturday 8th November 2025 to inter alia to consider and approve the unaudited Financial Results of the Company for the quarter and half year ended 30th September 2025.
10 months agoIn compliancce with regulation 74(5) of SEBI(DP) Regulation 2018 We are enclosing herewith a copy of certificate received from our registrar and Share transfer agent Datamatics Business Solutions Limited for the quarter ended 30th September 2025.
10 months agoTrading/dealing in securities shall remain closed from with effect from 1st October 2025 and shall re open 24 hours after the unaudited Financial result of the company fr the quarter ended 30th September 2025 become generally available.
11 months agoWith reference to regulation 44(3) of SEBI LODR the details of voting results along with conslidated Scrutinizers Report on remote e voting and e voting at the meeting are enclosed herewith.
11 months agoPursuant to requireent specified under regulation 30 of Securities and Exchange Board of India (LODR) we enclose herewith proceedings of 38th AGM of Pentokey organy India Limited held on 27th September 2025 at 3.00 PM through Video Conferencing (VC)/ Other Audio Visual Means(OAVM).
11 months agoWe hereby enclose e copies of newspaper advertisement pblished on 4th September 2025 in english newspaper Financial Express all editions and Local languge newspaper Pratahkal(Mumbai edition) informing about 38th AGM scheduled on 27th September 2025 at 3.00 PM through VC/OAVM.
11 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
509, Western Edge I Western Express Highway Borivali (East) Mumbai Maharashtra PIN: 400066 Tel No: 022 28545118 / 19 Fax No: NULL Email: [email protected] Internet: www.pentokey.com
Registrars
Plot No. A 16 & 17, Part B Cross Lane,MIDC, Andheri East, Mumbai 400093Old Address: Plot No. B5, Part B Cross Lane,MIDC, Andheri (E), MumbaiMaharashtra – 400 093Tel.: 022 66712001-06,Fax: 022 66712011Email: [email protected] Plot No. A 16 & 17 Part B Cross Lane MIDC, Andheri (E) PIN: Tel No: 022 66712001-06 Fax No: 022 66712011 Email: [email protected]
Management
Purshottam Kejriwal, Non Independent & Non Executive Director
Prajakta Shidhore, Non Executive Independent Director
Arun Goenka, Non Independent & Non Executive Director
Kostuv Kejriwal, Non Independent & Non Executive Director
Saurabh Mishra, Company Secretary & Compliance Officer
Haroon Hasan Siddiqi, Non Executive Independent Director
Details
BSE 524210
NSE NULL
ISIN INE702E01015